Iran diplomacy may be gaining momentum as talks over the Strait of Hormuz and a potential Israel–Iran ceasefire reshape prediction markets across the region. Alex Keeney and Domer also examine the political pressure on Rep. Max Miller and the backlash to Kalshi’s controversial markets tied to cancer trials and regulatory outcomes. Plus, Rashan Colbert breaks down the CLARITY Act’s increasingly difficult path through the Senate, while Natalie Fertig explains the latest on federal marijuana rescheduling and what a move from Schedule I to Schedule III could mean.
Iran diplomacy may be gaining momentum, the Strait of Hormuz could be headed toward a new security arrangement, and the Senate’s path to passing major crypto legislation is looking increasingly uncertain.
Alex Keeney and Domer break down the prediction markets around Rep. Max Miller’s political future, an Israel–Iran ceasefire, U.S.–Iran negotiations, Hormuz traffic, Houthi escalation, and the odds of regime change in Iran. They also examine the latest backlash facing prediction markets after Kalshi drew criticism for contracts tied to cancer trials and regulatory decisions.
Rashan Colbert joins the show to assess the CLARITY Act and whether the landmark crypto market-structure bill has any realistic path through a chaotic Senate before recess.
Finally, cannabis policy reporter Natalie Fertig explains the renewed push to reschedule marijuana, the slow-moving DEA and DOJ process, the difference between Schedule I and Schedule III, and what a change in federal policy could mean for cannabis businesses, research, patients, taxes, and state legalization efforts.